Welcome : Guest

MultiVir, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about MultiVir, Inc., which is principally a Clinical-Stage Gene Therapy Company. Illustrated with 6 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64933
Price: $300
Company Type: Public
Pages: 8
Date: January 2016
Market Data Tables: 6

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Gene Therapy......2
Table 1: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......2
Table 2: Gene Therapy Clinical Trials Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Phase I, n=1183, Phase I/II, n=384, Phase II, n=330, Phase II/III, n=20 and Phase III, n=74......3
DNA & Gene Chip (Microarray)......4
Table 3: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......4
Gene Sequencing......5
Table 4: Global Top 3 Gene Sequencing Tool Manufacturers’ Market Share by Value (2014) for Illumina, Roche, Life Sciences, and Others......5
Table 5: Global Top 3 Next Gene Sequencing Vendors Market Share (2014) by Value for Illumina Inc., Life Technologies Corporation, Roche NimbleGen Inc., and Others......6
DNA Genotyping......7
Table 6: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......8